AACCP

The article discusses anticoagulation therapy, focusing on warfarin and newer agents like dabigatran, rivaroxaban, and apixaban. It outlines the indications, dosing, management of therapy, and monitoring practices for these medications, emphasizing the importance of individualized treatment based on patient risk factors. The guidelines from the American College of Chest Physicians are referenced for various conditions requiring anticoagulation, including atrial fibrillation and venous thromboembolism. The article also highlights the benefits of patient self-testing for INR and the evolving landscape of anticoagulation management.

The article discusses anticoagulation therapy, focusing on warfarin and newer agents like dabigatran, rivaroxaban, and apixaban. It outlines the indications, dosing, management of therapy, and monitoring practices for these medications, emphasizing the importance of individualized treatment based on patient risk factors. The guidelines from the American College of Chest Physicians are referenced for various conditions requiring anticoagulation, including atrial fibrillation and venous thromboembolism. The article also highlights the benefits of patient self-testing for INR and the evolving landscape of anticoagulation management.